The FDA established its accelerated approval program in 1992 to allow drugs to reach the market quickly for life-threatening ...
Following the ban of red dye No. 3 in the United States, experts weigh in on the potential health risks of red dye No. 40, ...
Of the 24 drugs, three approvals deviated from the others -- aducanumab; the synthetic hormone hydroxyprogesterone caproate ...
The review, which was spurred by controversy over the FDA's Aduhelm approval, recommends two main changes in agency ...
The FDA has approved the combination of sotorasib (Lumakras) and panitumumab (Vectibix) for the treatment of patients with ...
The FDA wants the developers of medical devices that rely on AI to disclose more detail about how their devices were ...
The U.S. Food and Drug Administration has issued a proposed rule that, if finalized, would make cigarettes and certain other combusted tobacco ...
Dr. Scott Manthei of the Nevada Ear and Sinus Institute has been advising patients against taking drugs like Sudafed for ...
Nicotine levels would be reduced by up to 95% compared with traditional cigarettes. The U.S. would be the only country with ...
The FDA announced its draft guidance on recommendations for studies assessing pulse oximeters to ensure the devices perform ...
The Biden administration's Food and Drug Administration (FDA) released additional details on a proposed rule that would ...
Approvals for drugs from Biogen Inc. and Sarepta Therapeutics Inc. show flaws in the process US drug regulators use to speed ...